Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

Radiopharm Theranostics Ltd (ASX:RAD, OTC:RDPTF, NASDAQ:RADX) has dosed the first patient in a Phase 1 clinical trial of its ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...

Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...